Michael S. Wyzga Mba
Board of Directors
The F. Dohmen Co.
United States of America
Mr. Michael S. Wyzga, also known as Mike, MBA, serves as the Chief Financial Officer of Aura Biosciences, Inc. Mr. Wyzga served as an Advisor of Radius Health, Inc. since November 2013. Mr. Wyzga served as an Executive Vice President of Finance at Sanofi Biosurgery (formerly, Genzyme Biosurgery Corporation) since May 2003 and its Chief Accounting Officer since January 1999 and also Chief Financial Officer since July 1999. He served as the Chief Executive Officer and President of Radius Health, Inc., from December 5, 2011 to November 11, 2013. He served as an Executive Vice President of Finance at Genzyme Oncology, Inc. (also known as Genzyme Molecular Oncology, an affiliate of Genzyme Tissue Repair) since May 2003 and its Chief Financial Officer since July 1999 and Chief Accounting Officer since January 1999. He is a biotechnology consultant and has extensive experience in the biotechnology industry. He served as an Executive Vice President of Finance at Genzyme Corporation since May 2003. He served as the Chief Financial Officer of Genzyme Corporation since July 1999. Mr. Wyzga served as the Chief Accounting Officer of Genzyme Corporation until December 2008 and its Principal Accounting Officer since January 1999. He served as Chief Financial Officer, Chief Accounting Officer, Corporate Controller and Senior Vice President - Finance at Genzyme Surgical Products. From January 1999 to July 1999, he served as Senior Vice President, Corporate Controller of Genzyme Corporation and Senior Vice President of Finance from July 1999 to May 2003. He served as the Chief Financial & Accounting Officer and Senior Vice President of Finance at Genzyme General since July 1999. He served as Vice President of Genzyme Biosurgery Corporation since February 1998, Senior Vice President from January 1999 to July 1999 and also Corporate Controller from February 1998 to July 1999. From February 1997 to February 1998, he served as the Chief Financial Officer of Sovereign Hill Software, Inc. From 1991 to 1997, he served various Senior Management Positions with CACHELINK Corporation and Lotus Development Corporation. Prior to his role at Sovereign Hill Software, Mr. Wyzga served as the Chief Financial Officer and Vice President of Finance for CacheLink Corporation and held various management positions at Lotus Development Corporation, including Vice President of Finance and Director of Plans and Controls. He held management positions at Digital Equipment Corp. He has been Chairman of the Board at GenSight Biologics SA since 2016. He has been an Independent Director of Exact Sciences Corporation since February 9, 2015. He has been a Director of Akebia Therapeutics, Inc. since February 18, 2014. He has been Director of The F. Dohmen Co. since 2010. He has been an Independent Director of OncoMed Pharmaceuticals, Inc. since October 18, 2013 and GenSight Biologics SA since July 2015. He has been a Member of Supervisory Board of BioMarin Nederland B.V. since June 17, 2014. He serves as Board Member of Citi Performing Arts and Providence College Business School. He served as a Director of Idenix Pharmaceuticals Inc. from March 1, 2012 to August 2014. He served as a Director of Radius Health, Inc., from December 5, 2011 to November 2013. He served as an Independent Director of Altus Pharmaceuticals Inc. since May 2004. He served as a Director of BioMarin Nederland B.V. Mr. Wyzga received an M.B.A. in Business Administration from Providence College and a B.S. in Business Administration from Suffolk University.
Finance , Business and Marketing